FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20200720E00306
1. Date of relevant event: 08/07/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 09989
4. Name of listed corporation: Shenzhen Hepalink Pharmaceutical Group Co., Ltd. - A Shares 
5. Class of shares: A Shares 
6. Number of issued shares in class: 1,247,201,704
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Shan
(Other names) Yu
10. Name of director (Chinese): 單宇 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1701Miscellaneous
On listing of the corporation or a class of shares of the listed corporation
 
 
 
         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
   
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position52,302,8924.19
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position46,425,600
2101Beneficial owner
Long position5,877,292
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Urumqi Shuidi Shichuan Equity Investment Partnership (Limited Partnership)2015-584, Cyberport Building, No. 258 Gaoxin Street, Urumqi High-tech Industrial Development Zone (New District), Xinjiang, PRCShan Yu99.00Y
Long position46,425,600
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Shan Yu held his interests in box 26 as to 46,425,600 A Shares through a controlled corporation, and as to 5,877,292 A Shares through his participation in the Company's Share Incentive Scheme II in which he has a 38.88% interest in 15,118,035 A Shares held by the asset manager for the benefit of the participants of the scheme. For details, please refer to the Company's prospectus dated June 24, 2020.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 20/07/2020
(dd/mm/yyyy)